Recent Comments
- John Polk said “I knew Charles when he was EVP of The Atlanta Chamber and I worked for ...” on Memories of Oklahoma City circa 1993
- John Polk said “Back in the mid-80's and early 90's, Cleveland was actually recognized as one of the ...” on Economic development in NEO: A view from the street-level
- John Polk said “Is there any way to substantiate Dimora's claim re: GCP and the PD, other than ...” on Cleveland’s new development dynamic?
- George Nemeth said “Like all glimmers of newness in CLE+ I expect this one to be crushed too” on Cleveland’s new development dynamic?
- Cleveland’s new development dynamic? | Brewed Fresh Daily said “[...] by Ohio voters, as gambling interests convert the Ohio constitution into a zoning ordinance. ...” on Ohio’s casino deal gets a bit more messy
- About BDP Comments
Meta
Ed Morrison · Biosensor development in Akron
September 10th, 2010
The Austen BioInnovation Institute in Akron (ABIA) has received a more than $2.6 million research and commercialization grant for biomedical sensor technology from The Wright Center for Sensor Systems Engineering (WCSSE) through the Ohio Third Frontier initiative. The ABIA project is one of six grants recently announced, totaling more than $17 million, focused on the development and commercialization of sensors and sensor technologies, with the ultimate goal of creating high-impact technology jobs for Ohio.
ABIA is working with seven Ohio institutions including The University of Akron, one of its founding members, on the biomedical sensor project as well as the Bertec Corporation, Case Western Reserve University, The Cleveland Clinic Foundation, Cleveland Veterans Administration, Future Path Medical, Ohio Willow Wood and Parker Hannifin Corporation.
The more than $2.6 million grant to ABIA – an exceptional collaboration of Akron Children’s Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Summa Health System, The University of Akron and John S. and James L. Knight Foundation – is focused on patient-centered innovation and commercialization meant to improve patient care by developing new sensor technologies that diagnose medical conditions and monitor patient health.
Last 5 posts by Ed Morrison
- Signing off - February 3rd, 2012
- "The current global development model is unsustainable" - February 1st, 2012
- Market opportunities for developing Chicago's green economy - January 29th, 2012
- Plain Dealer flubs its explanation for firing Tony Grossi - January 27th, 2012
- Linking and leveraging university assets to strengthen regional economies - January 27th, 2012
